SUMITOMO PHARMA CO., LTD. Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 410 JPY | +2,50% |
|
+5,40% | -12,02% |
| 22/04 | Luwte in geopolitieke spanningen tilt Aziatische aandelenmarkten op | MT |
| 17/04 | SUMITOMO PHARMA CO., LTD. : Jefferies & Co. blijft neutraal | ZM |
Totale waarde
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 1.087.401 | 557.406 | 765.586 | 479.930 | 321.807 | 162.889 | - | - |
| Bedrijfswaarde 1 | 937.295 | 724.961 | 816.227 | 545.994 | 524.701 | 455.213 | 465.681 | 471.758 |
| K/w-verhouding | 22,4 x | 13,7 x | 13,6 x | 8,51 x | -4,32 x | -0,82 x | -3,34 x | -8,3 x |
| Dividendrendement | 1,02% | 2% | 1,45% | 2,32% | 2,59% | - | - | - |
| Marktkapitalisatie/omzet | 2,37 x | 1,15 x | 1,48 x | 0,86 x | 0,58 x | 0,52 x | 0,47 x | 0,45 x |
| Bedrijfswaarde/omzet | 2,04 x | 1,5 x | 1,58 x | 0,97 x | 0,94 x | 1,44 x | 1,33 x | 1,31 x |
| Bedrijfswaarde/EBITDA | 13 x | 7,21 x | 8,69 x | 5,54 x | 9,11 x | -2,76 x | 20,2 x | 28,6 x |
| Bedrijfswaarde/FCF | 23,8 x | -2,72 x | 5,65 x | 42,1 x | -13 x | -3,58 x | -17,6 x | -233 x |
| FCF Yield | 4,21% | -36,8% | 17,7% | 2,37% | -7,72% | -27,9% | -5,69% | -0,43% |
| Price to Book | 2,18 x | 1,05 x | 1,32 x | 0,79 x | 0,79 x | 0,72 x | 0,95 x | 1,09 x |
| Aantal aandelen (in duizenden) | 397.297 | 397.295 | 397.294 | 397.293 | 397.292 | 397.291 | - | - |
| Referentieprijs 2 | 2.737 | 1.403 | 1.927 | 1.208 | 810,0 | 410,0 | 410,0 | 410,0 |
| Datum van publicatie | 10/05/19 | 13/05/20 | 12/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 459.267 | 482.732 | 515.952 | 560.035 | 555.544 | 316.260 | 349.728 | 359.056 |
| EBITDA 1 | 71.860 | 100.604 | 93.897 | 98.582 | 57.627 | -165.072 | 23.054 | 16.493 |
| Bedrijfsresultaat (EBIT) 1 | 57.884 | 83.239 | 71.224 | 60.234 | -76.979 | -200.985 | -44.049 | -15.766 |
| Operationele Marge | 12,6% | 17,24% | 13,8% | 10,76% | -13,86% | -63,55% | -12,6% | -4,39% |
| Resultaat voor belastingen (EBT) 1 | 65.046 | 83.947 | 77.851 | 82.961 | -47.920 | -197.567 | -47.130 | -18.631 |
| Nettowinst (verlies) 1 | 48.627 | 40.753 | 56.219 | 56.413 | -74.512 | -198.180 | -48.695 | -19.626 |
| Nettomarge | 10,59% | 8,44% | 10,9% | 10,07% | -13,41% | -62,66% | -13,92% | -5,47% |
| WPA 2 | 122,4 | 102,6 | 141,5 | 142,0 | -187,6 | -498,8 | -122,6 | -49,40 |
| Free Cash Flow 1 | 39.446 | -266.556 | 144.476 | 12.961 | -40.482 | -127.120 | -26.484 | -2.027 |
| FCF-marge | 8,59% | -55,22% | 28% | 2,31% | -7,29% | -40,19% | -7,57% | -0,56% |
| Kasstroomconversie (ebitda) | 54,89% | - | 153,87% | 13,15% | - | - | - | - |
| Kasstroomconversie (nettowinst) | 81,12% | - | 256,99% | 22,98% | - | - | - | - |
| Dividend per aandeel 2 | 28,00 | 28,00 | 28,00 | 28,00 | 21,00 | - | - | - |
| Datum van publicatie | 10/05/19 | 13/05/20 | 12/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: Maart | 2020 S1 | 2020 S2 | 2021 S1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 S1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 230.603 | 252.129 | 261.498 | 162.534 | 293.730 | 138.342 | 127.963 | 159.876 | 159.400 | 319.300 | 140.976 | - | 75.700 | 76.942 | 152.642 | 82.386 | 79.948 | 81.269 | - | 166.420 | - | - | 177.456 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -21.646 | - | - | - | - | - | - | - |
| Bedrijfsresultaat (EBIT) 1 | 66.835 | 16.404 | 47.539 | 39.266 | 47.572 | 10.656 | 2.006 | 14.614 | -43.500 | -28.900 | 11.138 | - | -51.600 | -34.898 | -86.498 | -31.247 | -51.031 | -18.664 | - | -36.422 | - | - | -9.217 |
| Operationele Marge | 28,98% | 6,51% | 18,18% | 24,16% | 16,2% | 7,7% | 1,57% | 9,14% | -27,29% | -9,05% | 7,9% | - | -68,16% | -45,36% | -56,67% | -37,93% | -63,83% | -22,97% | - | -21,89% | - | - | -5,19% |
| Resultaat voor belastingen (EBT) 1 | 64.147 | 19.800 | 43.654 | 41.309 | 49.266 | 16.317 | 17.378 | 46.610 | -25.610 | 21.000 | -18.842 | - | -31.100 | -25.027 | -56.127 | -49.064 | -75.454 | -18.754 | - | -36.602 | - | - | -9.397 |
| Nettowinst (verlies) 1 | 30.330 | 10.423 | 37.297 | 31.650 | 36.450 | 9.909 | 10.054 | 31.108 | -38.400 | -7.300 | -11.219 | - | -38.900 | -28.841 | -67.741 | -49.967 | -64.418 | -14.065 | - | -27.452 | - | - | -7.048 |
| Nettomarge | 13,15% | 4,13% | 14,26% | 19,47% | 12,41% | 7,16% | 7,86% | 19,46% | -24,09% | -2,29% | -7,96% | - | -51,39% | -37,48% | -44,38% | -60,65% | -80,58% | -17,31% | - | -16,5% | - | - | -3,97% |
| WPA 2 | 76,34 | - | 93,88 | 79,66 | 91,75 | 24,94 | 25,30 | 78,30 | -96,63 | -18,33 | -28,24 | -141,0 | -97,82 | -72,69 | -170,5 | -125,8 | -266,3 | -35,40 | - | -69,10 | - | - | -17,70 |
| Dividend per aandeel 2 | 14,00 | - | 14,00 | - | 14,00 | - | - | - | - | 14,00 | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Datum van publicatie | 28/10/19 | 13/05/20 | 28/10/20 | 27/10/21 | 27/10/21 | 31/01/22 | 13/05/22 | 29/07/22 | 31/10/22 | 31/10/22 | 31/01/23 | 15/05/23 | 31/07/23 | 31/10/23 | 31/10/23 | 31/01/24 | - | - | - | - | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
Balans
| Fiscaal tijdperk: Maart | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | 167.555 | 50.641 | 66.064 | 202.894 | 292.323 | 302.792 | 308.869 |
| Nettokaspositie 1 | 150.106 | - | - | - | - | - | - | - |
| Hefboom (schuld/ebitda) | - | 1,665 x | 0,5393 x | 0,6701 x | 3,521 x | -1,771 x | 13,13 x | 18,73 x |
| Free Cash Flow 1 | 39.446 | -266.556 | 144.476 | 12.961 | -40.482 | -127.121 | -26.484 | -2.027 |
| ROE (netto-inkomsten/eigen vermogen) | 10,2% | 7,9% | 10,1% | 9,5% | -14,7% | -59,2% | -18,7% | -6,58% |
| ROA (netto-inkomsten/totale activa) | 7,91% | 8,04% | 4,38% | 6,34% | -3,92% | -19,9% | -2,96% | -2,79% |
| Totale activa 1 | 614.659 | 506.723 | 1.283.539 | 889.478 | 1.899.145 | 994.132 | 1.645.849 | 702.755 |
| Nettoactief per aandeel 2 | 1.254 | 1.333 | 1.461 | 1.530 | 1.024 | 571,0 | 432,0 | 378,0 |
| Cashflow per aandeel 2 | 158,0 | 146,0 | 199,0 | 239,0 | -83,70 | -302,0 | -209,0 | 71,90 |
| Capex 1 | 9.265 | 7.722 | 6.048 | 7.347 | 14.600 | 14.080 | 12.280 | 12.280 |
| Capex/omzet | 2,02% | 1,6% | 1,17% | 1,31% | 2,63% | 4,45% | 3,51% | 3,42% |
| Datum van publicatie | 10/05/19 | 13/05/20 | 12/05/21 | 13/05/22 | 15/05/23 | - | - | - |
1JPY in Miljoen2JPY
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B
Verkoop
Koop
Gemiddeld advies
Onderwogen
Aantal analisten
8
Laatste slotkoers
410
JPY
Gemiddelde koersdoel
333,8
JPY
Spread / Gemiddelde doel
-18,60%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| -12,02% | 1,03 mld. | |
| +25,83% | 661 mld. | |
| +27,00% | 566 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers 4506
- Financiën Sumitomo Pharma Co., Ltd.
